|Bid||134.07 x 1000|
|Ask||134.36 x 800|
|Day's Range||130.49 - 137.45|
|52 Week Range||58.38 - 151.97|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||13.88|
|Earnings Date||Oct 26, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 28, 2020|
|1y Target Est||149.95|
HCA Healthcare reported mixed third-quarter results after pre-reporting strong revenue two weeks ago.
HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.
Shares of HCA Healthcare Inc. sank 3.6% in premarket trading Monday, after the hospital operator reported a third-quarter profit that came up short of expectations, while revenue rose above forecasts despite a drop in same-facility admissions. Net income rose to $668 million, or $1.95 a share, from $612 million, or $1.76 a share, in the year-ago period. the company said the results include a reversal of $822 million, or $1.72 a share, in government stimulus income recorded in the sequential second quarter. The FactSet consensus for earnings per share was $2.32, and the consensus for net EPS was $2.61. Revenue increased 4.9% to $13.31 billion, above the FactSet consensus of $12.90 billion. Same-facility admissions declined 3.8% and equivalent admissions fell 9.0%, as same-facility emergency room visits dropped 20.3% and same-facility inpatient surgeries declined 6.8%. Meanwhile, same-facility revenue per equivalent admission increased 14.8%, due to increases in acuity of patients treated and favorable payer mix. The stock has lost 7.6% year to date through Friday, while the SPDR Health Care Select Sector ETF has gained 5.9% and the S&P 500 has advanced 7.3%.